Delivery Order SPE2DE24D0021-SPE2D625F6S5V
- Not listed
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $1,808.52 for SOFIA SARS antigen FIA test kits (25-pack units) under a fixed-price contract with economic price adjustment provisions. The award, issued on July 21, 2025, with an ultimate completion date of September 2, 2025, will be performed in Pittsburgh, Pennsylvania. This delivery order represents a child contract under a larger vehicle and supports the Medical Supply Chain division of a defense-oriented federal...
- The U.S. government, through the Department of Defense's Medical Supply Chain agency, awarded a $2,750.00 fixed-price delivery order contract to Fisher Scientific Company L.L.C. for the provision of SOFIA 2 FLU + SARS antigen fluorescent immunoassay test kits. This contract has an ultimate completion date of December 24, 2024. Fisher Scientific, a major supplier of scientific products and equipment, will deliver the COVID-19 testing supplies to support pandemic response efforts. The contract...
- Fisher Scientific Company L.L.C. was awarded a delivery order by the Medical Supply Chain (Defense) on July 31, 2025, for the procurement of Sofia SARS antigen FIA test kits at a ceiling value of $1,356.39. This fixed-price contract with economic price adjustment provisions specifies delivery of 25-pack units of the Sofia rapid diagnostic test kits, with performance completion targeted for September 12, 2025. The work will be performed in Pittsburgh, Pennsylvania. This delivery order...
- The U.S. Defense Department's Medical Supply Chain awarded a fixed-price delivery order with economic price adjustment to Fisher Scientific Company L.L.C. on July 22, 2025, for the procurement of SOFIA 2 FLU + SARS 25S diagnostic testing supplies. The delivery order, valued at $4,423.36, represents a child contract with an ultimate completion date of September 17, 2025, and will be performed at Fisher Scientific's facility in Pittsburgh, Pennsylvania. This award was made through open competition...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2.7K on August 25, 2025, for the supply of Sofia SARS Antigen FIA (Fluorescence Immunoassay) test kits, 25 per pack, under a fixed-price contract with economic price adjustment provisions. The contract is a child order under a larger vehicle and carries an ultimate completion date of October 7, 2025. Performance will take place in Pittsburgh, Pennsylvania. This award was made by the Medical Supply Chain, a defense-focused...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a $3,900.06 fixed-price delivery order to Fisher Scientific Company L.L.C. for the purchase of SOFIA 2 FLU + SARS antigen fluorescent immunoassay tests. The award has a completion date of March 1, 2024. Fisher Scientific, a for-profit limited liability company and major supplier of scientific products to federal agencies, likely secured this order through one of its existing government-wide contract vehicles, which facilitate...
- This is a delivery order contract awarded by the Defense Department's Medical Supply Chain agency to Fisher Scientific Company L.L.C., a major supplier of scientific products, equipment, and services to federal agencies. The $5,500.00 fixed-price contract with economic price adjustment is for the delivery of SOFIA 2 FLU + SARS antigen fluorescent immunoassay test kits to support the Department of Defense's COVID-19 response efforts. The contract does not utilize any set-aside designations and...
- The U.S. Department of Defense Medical Supply Chain awarded a $1,100 delivery order to Fisher Scientific Company L.L.C. on September 11, 2025, for SOFIA 2 Flu + SARS Antigen Fluorescent immunoassay products. This fixed-price contract with economic price adjustment provisions has an ultimate completion date of November 7, 2025, and will be performed at Fisher Scientific's Pittsburgh, Pennsylvania facility. The award utilized no set-aside designation and represents a competitive procurement to...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $4,423.36 on July 31, 2025, for the supply of SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic test kits. This fixed-price delivery order with economic price adjustment will be performed in Pittsburgh, Pennsylvania, and is scheduled for completion by September 26, 2025. The contract was awarded without a set-aside designation through open competition to the Medical Supply Chain, a defense-focused federal agency. As a...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to Fisher Scientific Company L.L.C. on September 19, 2025, for SOFIA 2 Flu + SARS Antigen Fluorescent diagnostic supplies. This fixed-price contract with economic price adjustment carries a ceiling value of $1,100.00 and is scheduled for completion by November 18, 2025. The contract will be performed in Pittsburgh, Pennsylvania, and was awarded through open competition with no set-aside designation. As a child...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D625F6S5VDelivery Order
Fisher Scientific Company L.L.C., a major scientific supplier registered with the federal government since 2001, received a $2,700 fixed-price delivery order award from the Medical Supply Chain office under the Defense department on May 8, 2025, for SOFIA SARS Antigen FIA Test Kits (25 units per package). The contract, with an ultimate completion date of June 23, 2025, utilizes fixed-price pricing with economic price adjustment provisions and includes no set-aside designation, indicating open competition procurement. Performance will occur at Fisher Scientific's location in Pittsburgh, Pennsylvania. This delivery order represents a child contract under a larger procurement vehicle and supports federal biodefense and medical supply chain initiatives. Fisher Scientific's extensive track record supplying laboratory equipment, medical instruments, and specialized testing solutions to agencies including the National Institutes of Health, Department of Veterans Affairs, and Department of Defense positions the company as a qualified vendor for time-sensitive diagnostic testing needs. The SOFIA rapid antigen testing platform addresses potential pandemic preparedness and public health response requirements within the federal medical supply infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 5/8/25 |